Literature DB >> 12647790

Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine.

P Dziegiel1, J Forgacz, E Suder, P Surowiak, J Kornafel, M Zabel.   

Abstract

The study aimed at determining levels of metallothionein (MT) and Ki-67 antigen expression in adenocarcinomas of large intestine and examining relation of the expression levels with various clinical and pathological variables. The studies were performed on 81 cases of large intestine adenocarcinoma. Using immunocytochemistry, expressions of MT (positive reaction in 73 cases) and of Ki-67 (positive reaction in 79 cases) antigen were examined and the obtained results were compared with, i.a., grade (G) of the tumour and depth to which intestinal wall was infiltrated by individual tumours. Patient survival analysis was also performed, as correlated to expression levels of the two antigens. The obtained results permitted to disclose that the lower was grade of histological differentiation (G2, G3), the more pronounced was expression of MT and Ki-67. Also, the deeper was neoplastic infiltration of intestinal wall, the more pronounced was MT and Ki-67 expression. Despite the relatively strong correlation between MT expression and Ki-67 expression (r=0.536; p<0.05), only Ki-67 antigen expression in large intestine adenocarcinomas was inversely correlated to survival of the patients. Ki-67 proved to be a better prognostic marker, as compared to MT, in large intestine adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12647790     DOI: 10.14670/HH-18.401

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  14 in total

1.  High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Authors:  Thomas Ihmann; Jian Liu; Wolfgang Schwabe; Peter Häusler; Detlev Behnke; Hans-Peter Bruch; Rainer Broll; Ute Windhövel; Michael Duchrow
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-21       Impact factor: 4.553

2.  Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.

Authors:  Paweł Surowiak; Verena Materna; Irina Kaplenko; Marek Spaczyński; Manfred Dietel; Hermann Lage; Maciej Zabel
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

3.  Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer.

Authors:  Masayo Kawakami; Tatsuro Yamaguchi; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Shinichiro Horiguchi; Yukiko Hayashi; Nobuaki Funata; Takeo Mori
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

4.  Quantitative immunogold study of increased expression of metallothionein-I/II in the brain perivascular areas of diabetic scrapie-infected mice.

Authors:  Andrzej W Vorbrodt; Danuta H Dobrogowska; Harry C Meeker; Richard I Carp
Journal:  J Mol Histol       Date:  2006-09-21       Impact factor: 2.611

5.  Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma.

Authors:  Klaus Jürgen Schmitz; Carmen Ina Müller; Henning Reis; Hakan Alakus; Günther Winde; Hideo Andreas Baba; Jeremias Wohlschlaeger; Bharat Jasani; Joachim Fandrey; Kurt Werner Schmid
Journal:  Int J Colorectal Dis       Date:  2009-06-16       Impact factor: 2.571

6.  Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.

Authors:  Aleksandra Zamirska; Łukasz Matusiak; Piotr Dziegiel; Grażyna Szybejko-Machaj; Jacek C Szepietowski
Journal:  Pathol Oncol Res       Date:  2012-03-10       Impact factor: 3.201

7.  Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.

Authors:  Jaromir Gumulec; Martina Raudenska; Vojtech Adam; Rene Kizek; Michal Masarik
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 8.  Molecular functions of metallothionein and its role in hematological malignancies.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2012-07-27       Impact factor: 17.388

9.  Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival.

Authors:  Sandra F Martins; Ricardo Amorim; Sílvia Coelho Mota; Luís Costa; Fernando Pardal; Mesquita Rodrigues; Adhemar Longatto-Filho
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

10.  Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors.

Authors:  Emre Tuzel; Kutsal Yorukoglu; Esra Ozkara; Ziya Kirkali
Journal:  Cent European J Urol       Date:  2015-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.